Cargando…

Statins in heart failure: do we need another trial?

Statins lower serum cholesterol and are employed for primary and secondary prevention of cardiovascular events. Clinical evidence from observational studies, retrospective data, and post hoc analyses of data from large statin trials in various cardiovascular conditions, as well as small scale random...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonsu, Kwadwo Osei, Kadirvelu, Amudha, Reidpath, Daniel Diamond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3688443/ https://www.ncbi.nlm.nih.gov/pubmed/23807852 http://dx.doi.org/10.2147/VHRM.S44499

Ejemplares similares

Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis
por: Bonsu, Kwadwo Osei, et al.
Publicado: (2013)

Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis
por: Bonsu, Kwadwo Osei, et al.
Publicado: (2017)

Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies
por: Bonsu, Kwadwo Osei, et al.
Publicado: (2016)

Effectiveness and safety of statins on outcomes in patients with HIV infection: a systematic review and meta-analysis
por: Vigny, Njeodo Njongang, et al.
Publicado: (2022)

Paradigm Shifts of Heart Failure Therapy: Do We Need Another Paradigm?
por: Lee, Hae-Young, et al.
Publicado: (2020)

Why We Do Need Another Medical Journal…
por: Malbrain, Manu L. N. G.
Publicado: (2013)

Do we really need another risk prediction rule? Yes, we do
por: Lo, Alexander X., et al.
Publicado: (2022)

Do we need another neural correlate of contour integration?
por: de-Wit, Lee, et al.
Publicado: (2014)

Treatment of Iatrogenic esophageal perforation: Do we need another tool?
por: Barthet, Marc, et al.
Publicado: (2015)

Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
por: Lagniau, Sabrina, et al.
Publicado: (2017)

Do we need another prognostic score for cardiogenic shock patients with ECMO?
por: Champion, Sébastien
Publicado: (2017)

Do We Really Need Another Special Issue on NF-κB in Cancer and Inflammation?
por: Geismann, Claudia, et al.
Publicado: (2019)

Do we need a definition of acute heart failure with preserved ejection fraction?
por: Kapłon-Cieślicka, Agnieszka, et al.
Publicado: (2021)

Provision of palliative care for chronic heart failure inpatients: how much do we need?
por: Harding, Richard, et al.
Publicado: (2009)

Do Not Treat Children with Statins
por: Diamond, David M., et al.
Publicado: (2019)

Echo and heart failure: when do people need an echo, and when do they need natriuretic peptides?
por: Modin, Daniel, et al.
Publicado: (2018)

Social support in type II diabetes care: a case of too little, too late
por: Kadirvelu, Amudha, et al.
Publicado: (2012)

The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?
por: Kostikas, Konstantinos, et al.
Publicado: (2016)

Do We Need Another CT Scanner?—The Pilot Study of the Adoption of an Evolutionary Algorithm to Investment Decision Making in Healthcare
por: Kolasa, Katarzyna, et al.
Publicado: (2023)

Yet another reason we need to tackle socioeconomic inequalities in smoking
por: Green, Michael J.
Publicado: (2022)

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Empathy levels among first year Malaysian medical students: an observational study
por: Williams, Brett, et al.
Publicado: (2014)

Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
por: Loh, Darren Kin Wai, et al.
Publicado: (2022)

Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013)

Atrial fibrillation in heart failure: what should we do?
por: Kotecha, Dipak, et al.
Publicado: (2015)

Sex Differences in Heart Failure: What Do We Know?
por: Arata, Allegra, et al.
Publicado: (2023)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Heart Failure—Do We Need New Drugs or Have Them Already? A Case of Coenzyme Q10
por: Filipiak, Krzysztof J., et al.
Publicado: (2022)

Sympathoinhibitory effect of statins in chronic heart failure
por: Gomes, Marc E., et al.
Publicado: (2009)

Appropriate candidates for statin use in heart failure
por: Seo, Hong Seog
Publicado: (2014)

Peer mentoring experience on becoming a good doctor: student perspectives
por: Mohd Shafiaai, Mohd Syameer Firdaus, et al.
Publicado: (2020)

Do we need clinical trials to test the ability of transdermal HRT to prevent coronary heart disease?
por: Crook, David
Publicado: (2001)

Will We Be Known by Another Name?
Publicado: (1894)

Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?
por: Iyngkaran, Pupalan, et al.
Publicado: (2019)

Another failure to wean away from fossil fuels: Can we risk it?
por: The Lancet Regional Health – Southeast Asia
Publicado: (2022)

The myosin activator: is another step forward in heart failure therapy?
por: Abete, Raffaele, et al.
Publicado: (2021)

Coronary Artery Fistula as Another Cause of Acute Heart Failure
por: Pérez Mijenes, Danay, et al.
Publicado: (2023)

Antioxidants in Pregnancy: Do We Really Need More Trials?
por: Di Fabrizio, Carolina, et al.
Publicado: (2022)

Do we need to reconsider how we design and conduct randomized controlled trials?
por: Batra, Gorav, et al.
Publicado: (2022)

Diversity in modern heart failure trials: Where are we, and where are we going
por: Anaba, Uzoma, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q8m8uf1n8n8b4fcpo3cm3ge6tk